As of April 16, 2025, Nanoform Finland Oyj (NANOFH.HE) has a market cap of $0.10 billion USD. According to our data, Nanoform Finland Oyj is ranked No.7551 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.10 B |
-23.20%
|
Dec 29, 2024 | $0.13 B |
-12.15%
|
Dec 28, 2023 | $0.15 B |
-50.62%
|
Dec 29, 2022 | $0.31 B |
-51.37%
|
Dec 29, 2021 | $0.64 B |
-7.06%
|
Dec 29, 2020 | $0.68 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Nanobiotix
NBTX
|
$0.16 B |
0.000 M
|
![]() France
|
![]() BioNTech
BNTX
|
$23.80 B |
0.001 M
|
![]() Germany
|
![]() Moderna
MRNA
|
$10.14 B |
-0.001 M
|
![]() USA
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
Market Cap | = | NANOFH.HE Stock Price | * | NANOFH.HE Shares Outstanding |
= | $1.20 | * | 85.53 M | |
= | $0.10 B |